Announcements / Notices
|
|
|
|
|
Far East Consortium International Limited 00035.HKSUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTIONS IN RELATION TO THE DISPOSAL OF OFFICE, HOTEL AND TOWN HALL IN THE UNITED KINGDOMNovember 03
Shoucheng Holdings Limited 00697.HKVoluntary Announcement - Regarding the Investment in CICC Cainiao Logistics REITNovember 03
CSPC Pharmaceutical Group Limited 01093.HKVOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6088 INJECTION FOR THE TREATMENT OF ADVANCED SOLID TUMOURS OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINANovember 03CSPC Pharmaceutical Group Limited 01093.HKVOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2072 TABLETS FOR THE TREATMENT OF UNCONTROLLED HYPERTENSION AND RESISTANT HYPERTENSION OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINANovember 03
Crystal International Group Limited 02232.HKANNOUNCEMENT ON THE RENEWAL OF EXISTING CONNECTED TRANSACTIONS AND THE CONNECTED LEASES OF CRYSTAL TOWERNovember 03
PINE Technology Holdings Limited 01079.HKRESULTS OF THE RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY TWO (2) EXISTING SHARES HELD ON THE RECORD DATE ON A NON-UNDERWRITTEN BASISNovember 03
China Communications Services Corporation Limited 00552.HKList of Directors and their Role and FunctionNovember 03China Communications Services Corporation Limited 00552.HKResignation of Non-Executive DirectorNovember 03
Hainan Meilan International Airport Company Limited 00357.HKLIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONSNovember 03
Ju Teng International Holdings Limited 03336.HKOverseas Regulatory Announcement (Chinese version only)November 03
First Pacific Company Limited 00142.HKOverseas Regulatory Announcement: Disclosure Filed by PLDT Inc. ("PLDT"), a Major Operating Associate of First Pacific Company Limited, with the Philippine Stock Exchange, in relation to the SEC Form 17-C and Form 4-9 in Connection with the Resignation and Replacement of the External Auditor of PLDT.November 03
Heng Tai Consumables Group Limited 00197.HKCLOSURE OF REGISTER OF MEMBERS AND NOTICE OF ANNUAL GENERAL MEETINGNovember 02Heng Tai Consumables Group Limited 00197.HK2025/26 ANNUAL RESULTS ANNOUNCEMENT AND RESUMPTION OF TRADINGNovember 02
Huiyuan Cowins Technology Group Limited 01116.HKCLARIFICATION ANNOUNCEMENT IN RELATION TO THE 2026 ANNUAL REPORTNovember 02
Walnut Capital Limited 00905.HKINSIDE INFORMATION (1) PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER; (2) CLARIFICATION IN RELATION TO THE TRADING HALT; AND (3) RESUMPTION OF TRADINGNovember 02Lotus Horizon Holdings Limited 06063.HKUPDATE ON STATUS OF PUBLIC FLOAT AND GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH THE MINIMUM PUBLIC FLOAT REQUIREMENTNovember 02CSPC Pharmaceutical Group Limited 01093.HKVOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF PRUSOGLIPTIN TABLETS IN COMBINATION WITH DAPAGLIFLOZIN TABLETS AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS ACHIEVES POSITIVE TOPLINE RESULTSNovember 02CSPC Pharmaceutical Group Limited 01093.HKVOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6052 (RECOMBINANT HERPES ZOSTER VIRUS VACCINE (CHO CELLS)) OFFICIALLY INITIATED IN CHINANovember 02CSPC Pharmaceutical Group Limited 01093.HKVOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYS6057 (RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS VACCINE (CHO CELLS)) OFFICIALLY INITIATED IN CHINANovember 02C&N Holdings Limited 08430.HK(1) PROPOSED CAPITAL REORGANISATION; AND (2) PROPOSED RIGHTS ISSUE ON THE BASIS OF FIVE RIGHTS SHARES FOR EVERY ONE ADJUSTED SHARE HELD ON THE RECORD DATENovember 02
Eternity Investment Limited 00764.HK(1) VERY SUBSTANTIAL DISPOSAL DISPOSAL OF PROPERTY AND (2) RESUMPTION OF TRADINGNovember 02
